PL1865961T3 - Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego - Google Patents

Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego

Info

Publication number
PL1865961T3
PL1865961T3 PL06739956T PL06739956T PL1865961T3 PL 1865961 T3 PL1865961 T3 PL 1865961T3 PL 06739956 T PL06739956 T PL 06739956T PL 06739956 T PL06739956 T PL 06739956T PL 1865961 T3 PL1865961 T3 PL 1865961T3
Authority
PL
Poland
Prior art keywords
treatment
famciclovir
herpes labialis
recurrent herpes
day
Prior art date
Application number
PL06739956T
Other languages
English (en)
Inventor
Stephan Billstein
Robert Charnas
Spotswood L Spruance
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/US2006/011498 external-priority patent/WO2006105216A1/en
Publication of PL1865961T3 publication Critical patent/PL1865961T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL06739956T 2005-03-30 2006-03-29 Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego PL1865961T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US66653605P 2005-03-30 2005-03-30
EP06739956A EP1865961B1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment
PCT/US2006/011498 WO2006105216A1 (en) 2005-03-30 2006-03-29 Famciclovir for the treatment of recurrent herpes labialis using a one-day treatment

Publications (1)

Publication Number Publication Date
PL1865961T3 true PL1865961T3 (pl) 2012-07-31

Family

ID=36829888

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06739956T PL1865961T3 (pl) 2005-03-30 2006-03-29 Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego

Country Status (15)

Country Link
US (4) US20100298353A1 (pl)
EP (2) EP1865961B1 (pl)
JP (3) JP2008534603A (pl)
KR (1) KR101312820B1 (pl)
CN (1) CN101678028A (pl)
AT (1) ATE545419T1 (pl)
AU (3) AU2006230269A1 (pl)
BR (1) BRPI0609793A2 (pl)
CA (1) CA2602641A1 (pl)
ES (1) ES2382664T3 (pl)
PL (1) PL1865961T3 (pl)
PT (1) PT1865961E (pl)
RU (2) RU2007139762A (pl)
TW (1) TW200716124A (pl)
WO (1) WO2006105194A2 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0141927B1 (en) 1983-08-18 1991-10-30 Beecham Group Plc Antiviral guanine derivatives
EP0182024B1 (en) 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (de) 1985-07-27 1990-06-21 Beecham Group Plc 9-substituierte guaninmonohydrate.
GB8628826D0 (en) 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
US5840763A (en) * 1994-12-12 1998-11-24 Smithkline Beecham Plc Treatment of a latent infection of herpes viruses
AU2006230269A1 (en) * 2005-03-30 2006-10-05 Novartis Ag Penciclovir or famciclovir for the treatment of recurrent genital herpes with a one-day application

Also Published As

Publication number Publication date
PT1865961E (pt) 2012-05-22
KR101312820B1 (ko) 2013-09-27
ES2382664T3 (es) 2012-06-12
CA2602641A1 (en) 2006-10-05
WO2006105194A3 (en) 2006-12-21
JP2015163614A (ja) 2015-09-10
RU2007139762A (ru) 2009-05-10
EP1865961B1 (en) 2012-02-15
US20120088781A1 (en) 2012-04-12
AU2010201834B2 (en) 2012-04-19
ATE545419T1 (de) 2012-03-15
JP6018473B2 (ja) 2016-11-02
CN101678028A (zh) 2010-03-24
AU2006230291A1 (en) 2006-10-05
BRPI0609793A2 (pt) 2010-04-27
US20120329814A1 (en) 2012-12-27
US20100298353A1 (en) 2010-11-25
WO2006105194A2 (en) 2006-10-05
AU2006230269A1 (en) 2006-10-05
AU2006230291A8 (en) 2013-10-24
US20150005324A1 (en) 2015-01-01
TW200716124A (en) 2007-05-01
AU2010201834A1 (en) 2010-05-27
JP2013049687A (ja) 2013-03-14
EP1865961A1 (en) 2007-12-19
JP2008534603A (ja) 2008-08-28
EP2363131A1 (en) 2011-09-07
RU2432951C2 (ru) 2011-11-10
KR20080004535A (ko) 2008-01-09
RU2007139758A (ru) 2009-05-10

Similar Documents

Publication Publication Date Title
NO2013015I2 (no) Elvitegravir i alle former beskyttet ved basispatentet
FI7594U1 (fi) Absorptiokappale kiinitettäväksi ihmiskehoon
PL1613350T3 (pl) Leczenie choroby autoimmunologicznej u pacjenta z nieodpowiednią odpowiedzią na leczenie inhibitorem TNFα
PL1755661T3 (pl) Gelsolina do stosowania w leczeniu infekcji
SI1900362T1 (sl) Derivati alfa-aminoamida, uporabni pri zdravljenju odvisnosti
WO2008043052A3 (en) Human antibodies neutralizing human metapneumovirus
WO2006128022A3 (en) Solid compositions and methods for treating middle-of-the night insomnia
HK1091141A1 (en) Compositions and methods for restoring sensitivity to treatment with her2 antagonists
FR2884826B1 (fr) Composition de polissage et procede de polissage l'utilisant
WO2005053607A3 (en) Method for preventing hepatic encephalopathic episodes
WO2006130433A3 (en) Treatment of ischemia using stem cells
PL1954281T3 (pl) Sposób leczenia raka
AR058173A1 (es) Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas
BR0307410A (pt) Uso de inibidores de pde5 no tratamento da cicatrização e fibrose
TW200742580A (en) Methods for treating nephrolithiasis
RS51122B (sr) Primena 5`-metiltioadenozina(mta) kod prevencije i/ili lečenja autoimunih bolesti i/ili pri odbacivanju transplantata
EP1949903B8 (en) Selective a2a receptor antagonists for the treatment of auricular fibrillation
WO2007109093A3 (en) Pyrazolo[1,5-a]pyrimidine derivatives and methods of use thereof
PL1865961T3 (pl) Famciklowir do leczenia nawracającej opryszczki wargowej z zastosowaniem leczenia jednodniowego
BRPI0408500A (pt) tratamento do diabetes do tipo 1 com inibidores de pde5
UY29532A1 (es) Derivados del ácido 6,7-dihidro-5h-imidazo(1,2-a)imidazol-3-sulfónico
WO2006083949A3 (en) Sepsis prevention through adenosine receptor modulation
GB0505076D0 (en) Medicament and treatment for herpes simplex and other infections
BRPI0414778A (pt) 6-aril-7-halo-imidazo[1,2-a]pirimidinas como agentes anticáncer
GB2401044B (en) A composition for use in the treatment or prophylaxis of a skin condition in a subject